PCLX-001 |
Catalog No.GC65891 |
PCLX-001은 각각 5nM(NMT1) 및 8nM(NMT2)의 IC50을 갖는 경구 활성 소분자 이중 NMT(N-myristoyltransferase) 억제제입니다. 821d96072c2d58d8970e76f526b0f6b8PCLX-001은 항종양 활성을 나타내며 초기 BCR(B-세포 수용체) 신호 전달을 억제하여 B-세포 악성 종양 연구에 사용할 수 있습니다.821d96072c2d58d8970e76f526b0f6b8
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1215011-08-7
Sample solution is provided at 25 µL, 10mM.
PCLX-001 is an orally acitve, small-molecule, dual N-myristoyltransferase (NMT) inhibitor, with IC50s of 5 nM (NMT1) and 8 nM (NMT2), respectively. PCLX-001 exhibits anti-tumor activity and inhibits early B-cell receptor (BCR) signaling, can be used to B-cell malignancies research[1][2].
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *